Tilray Brands (TLRY) Change in Accured Expenses (2017 - 2026)

Tilray Brands (TLRY) posted Change in Accured Expenses of -$10.6 million for Q1 2026, down 105.37% on a QoQ basis from -$5.2 million in Q4 2025, and up 18.98% year-over-year from -$8.9 million in Q1 2025.

Tilray Brands (TLRY) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Tilray Brands' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$10.6 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 18.98% year-over-year to -$10.6 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$5.9 million (up 12.42% YoY) and the FY2025 annual result came in at -$22.9 million, down 10919.81% from the prior year.
  • Change in Accured Expenses was -$10.6 million for Q1 2026 at Tilray Brands, down from -$5.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $31.2 million in Q2 2024 and bottomed at -$18.0 million in Q4 2023.
  • A 5-year average of -$1.4 million and a median of -$6.3 million in 2022 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 119.73% — and 2024, when it tumbled 1352.3%.
  • Tilray Brands' Change in Accured Expenses stood at $4.3 million in 2022, then plunged by 515.73% to -$18.0 million in 2023, then climbed by 9.01% to -$16.4 million in 2024, then jumped by 68.32% to -$5.2 million in 2025, then sank by 105.37% to -$10.6 million in 2026.
  • Business Quant data shows TLRY's Change in Accured Expenses at -$10.6 million in Q1 2026, -$5.2 million in Q4 2025, and -$5.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn -10.64 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -10.64 Mn
Feb 28, 2026 -10.64 Mn
Nov 30, 2025 -5.18 Mn
Nov 30, 2025 -5.18 Mn
Aug 31, 2025 -5.13 Mn
Aug 31, 2025 -5.13 Mn
May 31, 2025 15.02 Mn
May 31, 2025 15.02 Mn
Feb 28, 2025 -13.13 Mn
Feb 28, 2025 -13.13 Mn
Nov 30, 2024 -16.36 Mn
Nov 30, 2024 -16.36 Mn
Aug 31, 2024 -8.47 Mn
Aug 31, 2024 -8.47 Mn
May 31, 2024 31.19 Mn
May 31, 2024 31.19 Mn
Feb 29, 2024 -6.54 Mn
Feb 29, 2024 -6.54 Mn
Nov 30, 2023 -17.98 Mn
Nov 30, 2023 -17.98 Mn